Calcium channel blocker-simvastatin interaction (multiple letters)

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 5, 1999, Pages 583-585

  Tobert, J A ^a   Vega, J M ^a   Dobrinska, M ^a   Gruer, P J K ^a   Neuvonen, P J ^a   Kantola, T ^a   Kivisto, K T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 INHIBITOR; DILTIAZEM; ERYTHROMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ITRACONAZOLE; MEVINOLIN; MIBEFRADIL; PLACEBO; SIMVASTATIN; VERAPAMIL;

AREA UNDER THE CURVE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG METABOLISM; HUMAN; LETTER; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RHABDOMYOLYSIS;

CALCIUM CHANNEL BLOCKERS; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCLE WEAKNESS; MUSCLES; SIMVASTATIN; VERAPAMIL;

EID: 0032964060     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)